市场调查报告书
商品编码
1446993
2030 年冷泡泡棉泡壳包装市场预测:按材料、应用和地区分類的全球分析Cold Form Blister Packaging Market Forecasts to 2030 - Global Analysis By Material (Polypropylene, Aluminum, Oriented Polyamide, Polyvinyl Chloride, Polyethylene, Polyethylene Terephthalate and Other Materials), Application, and By Geography |
根据 Stratistics MRC 的数据,2023 年全球冷成型泡壳包装市场规模为 42.1 亿美元,预计到 2030 年将达到 75.4 亿美元,预测期内复合年增长率为 8.7%。
冷成型泡壳包装是一种包装药品和其他精緻产品的方法,其中泡壳在室温下形成而不是预先成型。它需要 PVC、铝和冷泡沫箔的组合,通常由铝和塑胶层的组合组成。与热成型泡壳相比,冷成型可实现更深的腔体、更复杂的设计以及更高的阻隔性。这种包装技术广泛应用于製药业,因为它可以保持产品稳定性并延长保质期。
根据国际药品製造商协会联合会统计,2020年共有53种新药上市,目前全球有超过9,000种化合物处于不同开发阶段。
製药业的成长
冷泡泡泡壳包装因其高阻隔阻隔性而广泛应用于製药领域,以确保敏感药品的安全、完整和保存。随着製药业在全球范围内不断扩张,对冷泡沫泡壳包装的需求不断增加。此外,这些行业强调遵守严格的监管标准,例如美国FDA 和欧洲药品管理局 (EMA),进一步推动了冷成型泡壳包装的采用。
初始投资高
投资能够生产高品质冷成型泡壳包装的最先进的机械需要大量的初始投资。这些机器很复杂,需要专门知识来操作和维护,进一步增加了初始投资负担。此外,包括铝箔和特种层压板在内的原材料采购可以进一步影响该市场的投资计划和盈利。
技术进步
技术进步涵盖製造流程、材料和设计能力的各个方面,有助于提高产品品质、效率和客製化。我们的设计能力允许对冷成型泡壳包装进行客製化和个性化。此外,创新的印刷技术实现了复杂的设计、品牌、序列化和监管要求,这是推动这一市场规模的一个因素。
缺乏意识
製药和医疗保健行业的製造商和相关人员可能没有接受过有关冷成型泡壳包装的良好教育。如果没有足够的教育,公司可能会忽略冷成型泡壳包装是满足其包装需求的可行解决方案,或者可能难以有效实施。此外,消费者可能缺乏对冷成型泡壳包装所提供的好处的认识,这可能会进一步阻碍该市场。
COVID-19 的影响
COVID-19大流行为冷泡沫泡壳包装市场带来了各种挑战。疫情扰乱了全球供应链和製造运营,导致供应链中断、原材料短缺和物流挑战。此外,严格的封锁措施和社交距离规定阻碍了业务运营,导致计划延迟并减少了包装技术和基础设施升级的投资,可能会影响我提供的冷成型泡壳包装的需求。
预计聚氯乙烯(PVC) 领域在预测期内将成为最大的领域
聚氯乙烯(PVC)部分预计将占据最大份额,因为它在为包装过程提供基本功能方面发挥着重要作用。 PVC 是一种热塑性聚合物,以其多功能性、耐用性和成本效益而闻名,使其成为泡壳包装的首选材料。此外,这些薄膜通常坚硬、耐刺穿,并且在包装过程中在相对较低的温度下易于热成型,从而推动了该领域的成长。
预计医疗保健产业在预测期内复合年增长率最高
由于医疗保健行业对产品保护、砸道机和患者安全的严格要求,预计在预测期内复合年增长率最高。医疗保健产品,尤其是药品,需要免受水分、氧气和光线等环境因素的影响,以保持其有效性和稳定性。此外,医疗保健行业经常处理各种形状和尺寸的产品,需要软包装解决方案,这正在推动该领域的成长。
在估计期间,欧洲占据了最大的市场占有率,因为冷泡沫泡壳包装在各行业(主要是製药和医疗保健)的采用不断增加。此外,一些领先公司越来越依赖冷成型泡壳包装,因为其卓越的阻隔性能可确保敏感药物免受湿气、氧气和污染。此外,该地区人口老化和慢性病盛行率上升进一步增加了市场需求。
预计北美在预测期内的复合年增长率最高,因为它使用具有阻隔性的专用铝基层压板,适合保护敏感的药品和保健产品。此外,在北美,FDA 等监管机构对包装和标籤实施了严格的规定,这也有助于冷成型泡壳包装的采用并支持在该地区的扩张。
According to Stratistics MRC, the Global Cold Form Blister Packaging Market is accounted for $4.21 billion in 2023 and is expected to reach $7.54 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Cold form blister packaging is a method of packaging pharmaceuticals and other sensitive products where the blister is formed at room temperature rather than being pre-formed. It involves a combination of PVC, aluminum, and a cold-form foil, typically composed of aluminum with a layer of plastic. Cold forming allows for deep cavities, intricate designs, and improved barrier properties compared to thermoformed blisters. This packaging technique is widely used in the pharmaceutical industry for its ability to maintain product stability and extend shelf life.
According to the International Federation of Pharmaceutical Manufacturers & Associations, in 2020, 53 new medicines were launched, while currently, more than 9,000 compounds are at different stages of development globally.
Pharmaceutical industry growth
Cold form blister packaging is extensively utilized in the pharmaceutical sector for its ability to provide high barrier properties, ensuring the safety, integrity, and shelf-life of sensitive drugs. As the pharmaceutical industry continues to expand globally, the demand for cold form blister packaging rises. Moreover, these industries' emphasis on compliance with stringent regulatory standards, such as those imposed by the FDA in the United States and the European Medicines Agency (EMA) in Europe, further drives the adoption of cold form blister packaging.
High initial investment
Investing in state-of-the-art machinery capable of producing high-quality cold form blister packaging involves significant upfront costs. These machines are complex and require specialized knowledge for operation and maintenance, further adding to the initial investment burden. Moreover, the procurement of raw materials, including aluminum foil and specialized laminates, can further impact investment planning and the profitability of this market.
Technological advancements
Advancements encompass various aspects of manufacturing processes, materials, and design capabilities, contributing to the enhancement of product quality, efficiency, and customization. Their design capabilities allow for greater customization and personalization of cold form blister packaging. Furthermore, innovative printing technologies enable intricate designs, branding, serialization, and regulatory requirements, which thereby drive this market size.
Lack of awareness
Manufacturers and stakeholders within the pharmaceutical and healthcare industries may lack sufficient education about cold form blister packaging. Without adequate education, companies may overlook cold form blister packaging as a viable solution for their packaging needs or may struggle to implement it effectively. Additionally, consumers may also lack awareness of the advantages offered by cold form blister packaging, which can impede this market further.
Covid-19 Impact
The COVID-19 pandemic has presented various challenges to the cold-form blister packaging market. As the pandemic disrupted global supply chains and manufacturing operations, it led to supply chain disruptions, raw material shortages, and logistical challenges. Additionally, stringent lockdown measures and social distancing regulations hindered business operations, leading to project delays and decreased investments in packaging technologies and infrastructure upgrades, potentially impacting the demand for cold-form blister packaging.
The polyvinyl chloride (PVC) segment is expected to be the largest during the forecast period
The polyvinyl chloride (PVC) segment is estimated to hold the largest share due to its crucial role in providing essential features to the packaging process. It is a thermoplastic polymer known for its versatility, durability, and cost-effectiveness, making it a preferred material for blister packaging. Additionally, these films are typically rigid and resistant to punctures and can be easily thermoformed at relatively low temperatures during the packaging process, thereby boosting this segment's expansion.
The healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment is anticipated to have highest CAGR during the forecast period due to its stringent requirements for product protection, tamper resistance, and patient safety. Healthcare products, particularly pharmaceuticals, require protection from environmental factors such as moisture, oxygen, and light to maintain their efficacy and stability. Moreover, the healthcare industry often deals with a wide range of product shapes and sizes, requiring a flexible packaging solution, which is driving this segment's growth.
Europe commanded the largest market share during the extrapolated period owing to increased adoption of cold form blister packaging across various industries, particularly pharmaceuticals and healthcare. Some of the major players are also increasingly relying on cold form blister packaging due to its superior barrier properties, ensuring the protection of sensitive drugs from moisture, oxygen, and contamination. In addition, the region's growing aging population and the rising prevalence of chronic diseases have further fueled the demand for this market in this region.
North America is expected to witness highest CAGR over the projection period, owing to the use of a special aluminum-based laminate that provides high barrier properties, making it suitable for protecting sensitive pharmaceuticals and healthcare products. Moreover, in North America, the stringent regulations imposed by regulatory bodies such as the FDA regarding packaging and labeling also contributed to the adoption of cold-form blister packaging, which is thereby propelling this region's expansion.
Key players in the market
Some of the key players in the Cold Form Blister Packaging Market include UFlex Limited, Amcor plc, SteriPackGroup, Constantia Flexibles, Sonoco Products Company, WestRock Company, Honeywell International Inc, Klockner Pentaplast, ACG, Bilcare Limited, Svam Toyal Packaging Industries Pvt. Ltd., Tekni-Plex, Inc., Essentra plc, Ningbo Dragon Packaging Technology Co., Ltd. And Wasdell Group.
In January 2024, Amcor announced a significant expansion of its North American thermoforming capabilities for the healthcare market.
In December 2023, Honeywell announced plans to enhance and strengthen its building automation capabilities with the acquisition of Carrier Global Corporation's Global Access Solutions business for $4.95 billion, in an all-cash transaction.
In September 2023, Amcor announced the North American launch of curbside-recyclable AmFiber(TM) Performance Paper packaging, part of the company's AmFiber portfolio.